2m 2m 2m 2m 2m 2m 2m
ATEA PHARMA (AVIR)
NASDAQ
$5.25+$0.15 (+2.92%)
Price as of Oct 02, 2026 4:10 PM EDT- $409.0MMarket Cap
- 80.85%1-Year Change
- BiotechnologyIndustry
ATEA PHARMA (AVIR)
$5.25+$0.15 (+2.92%)
AVIR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.10 | ||
Change | -$0.11 (-2.11%) | ||
Open | $5.16 | ||
High | $5.20 | ||
Low | $4.93 | ||
Previous Close | $5.21 | ||
Volume | 408,661 | ||
30-Day Average Volume | 302,100 | ||
1-Week Change | -1.35% | ||
1-Month Change | -7.10% | ||
1-Year Change | 80.85% | ||
3-Year Change | 70.00% | ||
5-Year Change | -87.86% | ||
Fundamentals | |||
Shares Outstanding | 80.2M | ||
Total Assets | $232.3M | ||
Market Cap | $409.0M | ||
Enterprise Value | $332.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.9M | ||
Free Cash Flow | -$37.1M | ||
EBIT | -$32.9M | ||
EBITDA | -$32.8M | ||
Net Working Capital | $200.5M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -12 | ||
PEG | -0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 11 | ||
Last Split Date | 02/14/2018 | ||
Earnings & Revenue